June 22 (Reuters) - Medadvisor Ltd (MDR) :
- COMPLETED A STRATEGIC REVIEW OF ITS OPERATIONS
- FY23 REVENUE EXPECTED TO BE IN RANGE OF A$95 MILLION TO A$97 MILLION
- PLANS TO REDUCE ITS AUSTRALIAN HEADCOUNT BY APPROXIMATELY 20% BY END OF JUNE 2023
- FY 23 EBITDA LOSS EXPECTED TO BE IN RANGE A$3.5 MILLION TO A$3.0 MILLION
- REDUCTION IN HEADCOUNT UNDERPINS ANNUAL COST SAVINGS OF CIRCA A$2 MILLION FOR FY24
- HAS POSITIONED ITSELF FOR PROFITABILITY IN FY24
- COMPANY'S CURRENT US PIPELINE IS MATERIALLY ABOVE PREVIOUS CORRESPONDING PERIOD
Add to My Watchlist
What is My Watchlist?